"Milrinone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase type 3 activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the inotropic potency of amrinone.
| Descriptor ID |
D020105
|
| MeSH Number(s) |
D02.092.080.085.543 D03.383.725.050.085.543
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Milrinone".
Below are MeSH descriptors whose meaning is more specific than "Milrinone".
This graph shows the total number of publications written about "Milrinone" by people in this website by year, and whether "Milrinone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 2 | 2 | 4 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Milrinone" by people in Profiles.
-
Clinical Interventions and Hemodynamic Monitoring in the Setting of Left Ventricular Systolic Heart Failure in Children: Insights From a Physiologic Simulator. Am J Ther. 2024 Sep-Oct 01; 31(5):e531-e540.
-
Milrinone therapeutic drug monitoring to reduce low cardiac output syndrome in pediatric patients. Can J Anaesth. 2023 05; 70(5):922-924.
-
Long-Term Ambulatory Intravenous Milrinone Therapy in Advanced Heart Failure. Heart Lung Circ. 2022 Dec; 31(12):1630-1639.
-
Relation of Right Atrial Strain to Mortality in Infants With Single Right Ventricles. Am J Cardiol. 2022 08 15; 177:137-143.
-
Subarachnoid Hemorrhage, Delayed Cerebral Ischemia, and Milrinone Use in Canada. Can J Neurol Sci. 2023 05; 50(3):380-388.
-
Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis. ESC Heart Fail. 2022 06; 9(3):2049-2050.
-
Intensive care management of right ventricular failure and pulmonary hypertension crises. Pediatr Pulmonol. 2021 03; 56(3):636-648.
-
Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era. Am J Ther. 2020 Oct 01; 28(6):e621-e630.
-
The effect of milrinone on hemodynamic and gas exchange parameters in children. Cardiol Young. 2020 Jan; 30(1):55-61.
-
Another Outcome Lost to the Benefits of Levosimendan? Pediatr Crit Care Med. 2019 10; 20(10):992-994.